Physician profile
Oby Ibe
NPI 1073000659
$1,434.52
in general payments reported to CMS, 2019-2025
6 companies · $576 in 2025
The $576 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $316 · 2023: $241 · 2024: $301 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,020 · Education: $98.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.62 |
| Education | $98.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $699.21 | 2022-2025 | Repatha, Repatha |
| Abbott Laboratories | $379.25 | 2022-2023 | Ensite, Gallant |
| Kestra Medical Technology Services, INC. | $174.14 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $97.33 | 2023 | Verquvo |
| Novo Nordisk INC | $42.62 | 2024-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $41.97 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oby Ibe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.